ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,149,762 | -13.6% | 19,803 | -19.9% | 0.01% | -11.1% |
| Q2 2023 | $1,330,408 | +55.9% | 24,715 | +15.0% | 0.01% | +50.0% |
| Q1 2023 | $853,503 | -4.1% | 21,488 | -2.8% | 0.01% | -14.3% |
| Q4 2022 | $889,727 | +125037.4% | 22,116 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $711 | -99.9% | 22,116 | -8.8% | 0.01% | 0.0% |
| Q2 2022 | $719,000 | +7.6% | 24,249 | +2.1% | 0.01% | +50.0% |
| Q1 2022 | $668,000 | -34.3% | 23,750 | +7.8% | 0.00% | -20.0% |
| Q4 2021 | $1,016,000 | +52.6% | 22,040 | +8.6% | 0.01% | +25.0% |
| Q3 2021 | $666,000 | -41.4% | 20,290 | -37.4% | 0.00% | -42.9% |
| Q2 2021 | $1,136,000 | +58.2% | 32,408 | +63.2% | 0.01% | +40.0% |
| Q1 2021 | $718,000 | +16.0% | 19,860 | -6.8% | 0.01% | 0.0% |
| Q4 2020 | $619,000 | -26.8% | 21,300 | -29.0% | 0.01% | -28.6% |
| Q3 2020 | $846,000 | +25.7% | 29,995 | +44.1% | 0.01% | +16.7% |
| Q2 2020 | $673,000 | -20.6% | 20,810 | 0.0% | 0.01% | -40.0% |
| Q1 2020 | $848,000 | -33.9% | 20,810 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $1,283,000 | -25.5% | 20,810 | -11.9% | 0.01% | -33.3% |
| Q3 2019 | $1,721,000 | +12.9% | 23,610 | +27.3% | 0.01% | 0.0% |
| Q2 2019 | $1,525,000 | +198.4% | 18,550 | +155.9% | 0.01% | +140.0% |
| Q1 2019 | $511,000 | +56.7% | 7,250 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $326,000 | -6.3% | 7,250 | +17.9% | 0.00% | +50.0% |
| Q3 2018 | $348,000 | -7.2% | 6,150 | +9.6% | 0.00% | -33.3% |
| Q2 2018 | $375,000 | +14.7% | 5,611 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $327,000 | -9.7% | 5,611 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $362,000 | +22.7% | 5,611 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $295,000 | +5.0% | 5,611 | -1.0% | 0.00% | -66.7% |
| Q1 2017 | $281,000 | -18.1% | 5,666 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $343,000 | -8.8% | 5,666 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $376,000 | +30.6% | 5,666 | +9.7% | 0.00% | +33.3% |
| Q2 2016 | $288,000 | +23.6% | 5,166 | 0.0% | 0.00% | +50.0% |
| Q4 2015 | $233,000 | -28.7% | 5,166 | -37.5% | 0.00% | -33.3% |
| Q3 2015 | $327,000 | -58.4% | 8,266 | -34.7% | 0.00% | -50.0% |
| Q2 2015 | $786,000 | -18.2% | 12,666 | -17.6% | 0.01% | -14.3% |
| Q1 2015 | $961,000 | – | 15,366 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |